Risk and Predictors of Mortality Associated With Chronic Hepatitis B Infection

References

Page 1

	Year	Citations
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level Chien‐Jen Chen JAMA	2006	3.1K
Chronic hepatitis B Anna S. Lok, Brian J. McMahon Hepatology Hepatitis DHepatologyViral HepatitisHepatitis BHepatitis	2007	3.1K
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS R. Palmer Beasley, Chia‐Chin Lin, Lu‐Yu Hwang The Lancet Hepatitis DHepatologyViral HepatitisHepatitis BHepatitis	1981	2.9K
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease Yun‐Fan Liaw, Joseph J.�Y. Sung, Wan Cheng Chow, New England Journal of Medicine	2004	2.3K
Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in Children Mei‐Hwei Chang, Chien‐Jen Chen, Mei‐Shu Lai, New England Journal of Medicine	1997	1.9K
CHRONIC. HEPATITIS. B Mohammad Panahi, Mohammad Naderi, Taghavi Seyed Morteza, HepatologyViral HepatitisHepatitis BHepatitisMedicine	2007	1.7K
Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load Uchenna H. Iloeje, Hwai‐I Yang, Jun Su, Gastroenterology HepatologyDisease Risk AssessmentViral HepatitisLiver PhysiologyCirrhosis Risk	2006	1.5K
A mathematical model to estimate global hepatitis B disease burden and vaccination impact Susan T. Goldstein, Fangjun Zhou, Stephen C. Hadler, International Journal of Epidemiology	2005	737
Histological outcome during long-term lamivudine therapy Jules L. Dienstag, Robert Goldin, E. Jenny Heathcote, Gastroenterology HistopathologyClinical ReviewSurgeryPharmacotherapyLong-term Lamivudine Therapy	2003	727
Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B Stephanos J. Hadziyannis, Nicolaos C. Tassopoulos, E. Jenny Heathcote, New England Journal of Medicine	2005	535

Page 1